Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice1
暂无分享,去创建一个
M. Teixeira | M. Martins | A. Proudfoot | A. Talvani | T. Wells | A. Klein | P. M. R. Silva | Nick W. Luckacs
[1] D. C. Cara,et al. Mechanisms underlying eosinophil trafficking and their relevance in vivo. , 2000, Histology and Histopathology.
[2] D. C. Cara,et al. Stem Cell Factor Plays a Major Role in the Recruitment of Eosinophils in Allergic Pleurisy in Mice Via the Production of Leukotriene B41 , 2000, The Journal of Immunology.
[3] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[4] C. Serhan,et al. Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.
[5] C. Hogaboam,et al. Chemokines and asthma: redundancy of function or a coordinated effort? , 1999, The Journal of clinical investigation.
[6] P. Poubelle,et al. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit. , 1999, Journal of immunology.
[7] E. Allenspach,et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. , 1999, Journal of immunology.
[8] G. Yu,et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. , 1999, Journal of immunology.
[9] M. Lindsay,et al. Pharmacology of the eosinophil. , 1999, Pharmacological reviews.
[10] D. Taub,et al. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. , 1999, Journal of immunology.
[11] A. Proudfoot,et al. The CC Chemokine Receptor Antagonist Met–RANTES Inhibits Eosinophil Effector Functions , 1999, International Archives of Allergy and Immunology.
[12] M. Teixeira,et al. Priming and induction of eosinophil trafficking in guinea‐pig cutaneous inflammation by tumour necrosis factor α , 1998, British journal of pharmacology.
[13] M. Burdick,et al. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. , 1998, Journal of immunology.
[14] M. Perretti,et al. Resident mast cells are important for eotaxin‐induced eosinophil accumulation in vivo , 1998, Journal of leukocyte biology.
[15] C. Martínez-A,et al. The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.
[16] M. Laviolette,et al. Characteristics of leukotriene biosynthesis by human granulocytes in presence of plasma. , 1998, Biochimica et biophysica acta.
[17] D. Wilcox,et al. Effect of mast cell deficiency and leukotriene inhibition on the influx of eosinophils induced by eotaxin , 1997, Journal of leukocyte biology.
[18] A. Proudfoot,et al. The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 , 1997, European journal of immunology.
[19] S. Kunkel,et al. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. , 1997, The Journal of clinical investigation.
[20] M. Perretti,et al. Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. , 1997, Journal of immunology.
[21] J. Westwick,et al. Recombinant guinea pig and human RANTES activate macrophages but not eosinophils in the guinea pig. , 1997, Journal of immunology.
[22] M. Lindsay,et al. Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. , 1997, Blood.
[23] M. Perretti,et al. A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment , 1997, British journal of pharmacology.
[24] P. Leder,et al. Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.
[25] M. Cybulsky,et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. , 1996, The Journal of clinical investigation.
[26] M. Conklyn,et al. Characterization of the pharmacological profile of the potent LTB4 antagonist CP‐105,696 on murine LTB4 receptors in vitro. , 1996, British journal of pharmacology.
[27] M. Montjovent,et al. Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.
[28] M. Sticherling,et al. Role of eosinophil‐chemotactic C‐C chemokines in cutaneous inflammation , 1996, Journal of leukocyte biology.
[29] A. Luster,et al. Molecular characterization of two murine eosinophil beta chemokine receptors. , 1995, Journal of immunology.
[30] M. Teixeira,et al. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. , 1995, Trends in pharmacological sciences.
[31] E. Pettipher,et al. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. , 1995, The Journal of pharmacology and experimental therapeutics.
[32] R. Strieter,et al. Macrophage inflammatory protein‐1α influences eosinophil recruitment in antigen‐specific airway inflammation , 1995 .
[33] M. Teixeira,et al. Effect of a 5‐lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea‐pig , 1994, British journal of pharmacology.
[34] A. Shock,et al. Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea‐pig skin , 1994, British journal of pharmacology.
[35] R. Alam,et al. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. , 1994, Journal of immunology.
[36] R. L. Maas,et al. Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter. , 1982, Journal of immunology.
[37] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[38] A. Kay,et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. , 1991, The American review of respiratory disease.